206 related articles for article (PubMed ID: 14970264)
1. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
[TBL] [Abstract][Full Text] [Related]
2. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
3. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures.
Mattot V; Vercamer C; Soncin F; Calmels T; Huguet C; Fafeur V; Vandenbunder B
Oncogene; 2000 Feb; 19(6):762-72. PubMed ID: 10698494
[TBL] [Abstract][Full Text] [Related]
5. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
[TBL] [Abstract][Full Text] [Related]
6. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
7. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.
Giroux S; Kaushik AL; Capron C; Jalil A; Kelaidi C; Sablitzky F; Dumenil D; Albagli O; Godin I
Gene Expr Patterns; 2007 Jan; 7(3):215-26. PubMed ID: 17112790
[TBL] [Abstract][Full Text] [Related]
8. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
9. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation.
Bruhl T; Urbich C; Aicher D; Acker-Palmer A; Zeiher AM; Dimmeler S
Circ Res; 2004 Apr; 94(6):743-51. PubMed ID: 14764452
[TBL] [Abstract][Full Text] [Related]
10. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
11. Extra-embryonic vasculature development is regulated by the transcription factor HAND1.
Morikawa Y; Cserjesi P
Development; 2004 May; 131(9):2195-204. PubMed ID: 15073150
[TBL] [Abstract][Full Text] [Related]
12. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
Shivdasani RA; Mayer EL; Orkin SH
Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
[TBL] [Abstract][Full Text] [Related]
13. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
14. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
15. Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.
Namba K; Abe M; Saito S; Satake M; Ohmoto T; Watanabe T; Sato Y
Oncogene; 2000 Jan; 19(1):106-14. PubMed ID: 10644985
[TBL] [Abstract][Full Text] [Related]
16. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
17. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of transcription factor HESR1 on retinal vasculature.
Li B; Tang SB; Hu J; Gao Y; Zhang G; Lin SF; Chen JH; Li BJ
Microvasc Res; 2006 Nov; 72(3):146-52. PubMed ID: 17028039
[TBL] [Abstract][Full Text] [Related]
19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
20. Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3.
Iwatsuki K; Tanaka K; Kaneko T; Kazama R; Okamoto S; Nakayama Y; Ito Y; Satake M; Takahashi S; Miyajima A; Watanabe T; Hara T
Oncogene; 2005 Feb; 24(7):1129-37. PubMed ID: 15592512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
